Keeping You Connected

The SCCMA keeps you up to date on the latest news,
policy developments, and events

Local News


AMA, APHA, ASHP, Call for Immediate End to Prescribing, Dispensing, and Use of Ivermectin to Prevent or Treat COVID-19 Outside Clinical Trials

Following the FDA/CDC warning against the use of Ivermectin to prevent and treat COVID-19, the American Medical Association and other health care organizations issued a joint statement calling for an immediate end to the ordering, prescribing or dispensing of ivermectin for prevention or treatment of COVID-19. WASHINGTON, DC - The American Medical Association (AMA),  American Pharmacists Association (APhA),  and American Society of Health-System Pharmacists (ASHP) strongly oppose the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial. Ivermectin is approved by the U.S. Food and Drug Administration (FDA) ...

FDA/CDC Warn Against Use of Ivermectin to Prevent and Treat COVID-19

The Centers for Disease Control and Prevention (CDC) has issued a health alert warning physicians and the public about the rise in prescriptions for the anti-parasitic drug ivermectin for use in the treatment or prevention of COVID-19. The CDC also cautioned about the risk of severe illness caused by ivermectin, which was seen in increased calls to poison centers. Current NIH Treatment Guidelines state that there is insufficient evidence to recommend either for or against the use of ivermectin for the treatment of COVID-19 outside of clinical trials.   This recommendation is ...